The Novel HSP90 inhibitor, IPI-493, is highly effective in human gastrostrointestinal stromal tumor xenografts carrying heterogeneous KIT mutations (Q39511054)
Jump to navigation
Jump to search
scientific article published on 7 July 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The Novel HSP90 inhibitor, IPI-493, is highly effective in human gastrostrointestinal stromal tumor xenografts carrying heterogeneous KIT mutations |
scientific article published on 7 July 2011 |
Statements
1 reference
The Novel HSP90 inhibitor, IPI-493, is highly effective in human gastrostrointestinal stromal tumor xenografts carrying heterogeneous KIT mutations (English)
1 reference
Jasmien Wellens
1 reference
Maria Debiec-Rychter
1 reference
Patrick Schöffski
1 reference
Raf Sciot
1 reference
Thomas Van Looy
1 reference
Emmanuel Normant
1 reference
7 July 2011
1 reference
1 reference
17
1 reference
17
1 reference
5604-5614
1 reference
Identifiers
1 reference
1 reference